v1
Trimetrexate in advanced hormone-refractory prostate cancer. An ECOG phase II trial.
Identifier:nobleid.org/w1/20260515/F5C4DF5B
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/F5C4DF5B)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims